T. Rowe Price Investment Management, Inc.

Position in SRPT — Sarepta Therapeutics, Inc.

CIK 1897612 BALTIMORE, MD

Position in SRPT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$20,774,811

-$3,885,971 QoQ

Shares Held

1,156,083

+2.0% QoQ

Ownership

1.09%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#19

of 323 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

T. Rowe Price Investment Management, Inc. holds $12,305,680,119 across 52 Biotechnology names. SRPT ranks #41 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	6,754,846	$1,801,652,525
2	ALNY	Alnylam Pharmaceuticals, Inc.	5,642,173	$1,698,463,338
3	CYTK	Cytokinetics Inc	18,718,498	$1,594,628,844
4	KYMR	Kymera Therapeutics, Inc.	6,257,261	$717,520,118
5	PCVX	Vaxcyte, Inc.	12,207,450	$709,619,068
6	DYN	Dyne Therapeutics, Inc.	30,912,287	$686,561,894
7	CGON	CG Oncology, Inc.	6,616,899	$470,130,673
8	IMNM	Immunome Inc.	19,676,883	$416,953,150

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,774,811	1,156,083	+2.0%	Shares	Sole	2026-08-14
2026-03-31	$24,660,782	1,133,308	+206.4%	Shares	Sole	2026-05-15
2025-12-31	$7,958,763	369,831	-72.9%	Shares	Sole	2026-02-17
2025-09-30	$26,336,116	1,366,690	+187.9%	Shares	Sole	2025-11-14
2025-06-30	$8,118,361	474,758	-76.2%	Shares	Sole	2025-08-14
2025-03-31	$127,511,785	1,997,991	+2.1%	Shares	Sole	2025-05-14
2024-12-31	$237,900,926	1,956,583	+0.5%	Shares	Sole	2025-02-14
2024-09-30	$243,065,913	1,946,240	-0.6%	Shares	Sole	2024-11-14
2024-06-30	$309,464,330	1,958,635	+1.4%	Shares	Sole	2024-08-14
2024-03-31	$250,058,074	1,931,547	+0.6%	Shares	Sole	2024-05-15
2023-12-31	$185,120,721	1,919,742	+1.3%	Shares	Sole	2024-02-14
2023-09-30	$229,750,690	1,895,320	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.